Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Semaglutide
Canagliflozin
+2 more
Locations
119
United States
Novo Nordisk Investigational Site
Anaheim, California, United States
Novo Nordisk Investigational Site
La Mesa, California, United States
Novo Nordisk Investigational Site
Los Angeles, California, United States
Novo Nordisk Investigational Site
Montclair, California, United States
Novo Nordisk Investigational Site
San Diego, California, United States
Novo Nordisk Investigational Site
Spring Valley, California, United States
Start Date
March 15, 2017
Primary Completion Date
October 16, 2018
Completion Date
November 16, 2018
Last Updated
January 21, 2020
NCT07224321
NCT01399385
NCT07232537
NCT07340320
NCT06513026
NCT07536516
Lead Sponsor
Novo Nordisk A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions